Skip to main content
. 2023 Jan 10;277(2):275–283. doi: 10.1097/SLA.0000000000005054

Table 1.

Characteristics of Cohort

Characteristics RYGB Patients (n = 28,204) Nonobese Population Controls (n = 55,903) Nonoperated Obese Patients (n = 40,827) Nonobese Population Controls (n = 80,800)
Age, y, mean (SD) 40.8 (10.4) 40.8 (10.4) 43.1 (11.8) 43.1 (11.7)
Sex, no. (%)
Women 21,295 (75.5) 42,203 (75.5) 27,983 (68.5) 55,460 (68.6)
Outpatient, No (%) 20,829 (92.3) 33,737 (95.4)
Comorbidity, no. (%)
Hypertension 6731 (23.9) 1853 (3.3) 9540 (23.4) 3392 (4.2)
Diabetes mellitus 4151 (14.7) 954 (1.7) 6600 (16.2) 1689 (2.1)
Sleep apnoea 3459 (12.3) 518 (0.9) 6085 (14.9) 756 (0.9)
Coronary heart disease 806 (2.9) 568 (1.0) 2411 (5.9) 1383 (1.7)
Malignancy 759 (2.7) 1734 (3.1) 1900 (4.7) 3063 (3.8)
Ischemic stroke* 233 (0.8) 228 (0.4) 593 (1.5) 470 (0.6)
Myocardial infarction* 351 (1.2) 231 (0.4) 987 (2.4) 644 (0.8)
Marital status, no. (%)
Single 11,652 (41.3) 23,872 (42.7) 15,643 (38.3) 31,263 (38.7)
Married/cohabiting 12,011 (42.6) 24,348 (43.6) 17,563 (43.0) 36,791 (45.5)
Divorced/widowed 4292 (15.2) 7179 (12.8) 7031 (17.2) 11,592 (14.3)
Country of birth, no. (%)
Sweden 23,771 (84.3) 44,910 (80.3) 32,823 (80.4) 65,487 (81.0)
Education level, no. (%)
≤9 y 4859 (17.2) 6574 (11.8) 8432 (20.7) 11,654 (14.4)
10–12 y 17,327 (61.4) 25,354 (45.4) 22,002 (53.9) 36,876 (45.6)
>12y 5896 (20.9) 23,160 (41.4) 9987 (24.5) 31,157 (38.6)

Characteristics were derived at the study baseline, 2 years after obesity diagnosis for RYGB patients and nonoperated obese. Populations controls (matched for age, sex, and county of residence) were assigned the same start date as their matched case.

*

All individuals with a history of ischemic stroke or myocardial infarction at study baseline were excluded.

Missing data of marital status for 2497 (1.2%) individuals.

Missing data of education level for 2456 (1.2%) individuals.